Matthew C. Catley

BioPharmaceuticals R&D, AstraZeneca
Goeteborg, O, Sweden

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

Selective IL-27 production by intestinal regulatory T cells permits gut-specific regulation of Th17 immunity.

Selective IL-27 production by intestinal regulatory T cells permits gut-specific regulation of Th17 immunity.

Journal: bioRxiv : the preprint server for biology
Published: March 03, 2023

Selective IL-27 production by intestinal regulatory T cells permits gut-specific regulation of TH17 cell immunity.

Selective IL-27 production by intestinal regulatory T cells permits gut-specific regulation of TH17 cell immunity.

Journal: Nature immunology
Published: February 24, 2023

Enhancing SIRT1 Gene Expression Using Small Activating RNAs: A Novel Approach for Reversing Metabolic Syndrome.

Enhancing SIRT1 Gene Expression Using Small Activating RNAs: A Novel Approach for Reversing Metabolic Syndrome.

Journal: Nucleic acid therapeutics
Published: July 27, 2022

Delivery of Oligonucleotides to the Liver with GalNAc: From Research to Registered Therapeutic Drug.

Delivery of Oligonucleotides to the Liver with GalNAc: From Research to Registered Therapeutic Drug.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: May 07, 2020

Generation and characterization of a high affinity anti-human FcRn antibody, rozanolixizumab, and the effects of different molecular formats on the reduction of plasma IgG concentration.

Generation and characterization of a high affinity anti-human FcRn antibody, rozanolixizumab, and the effects of different molecular formats on the reduction of plasma IgG concentration.

Journal: mAbs
Published: August 22, 2018

Differential gene expression in human tissue resident regulatory T cells from lung, colon, and blood.

Differential gene expression in human tissue resident regulatory T cells from lung, colon, and blood.

Journal: Oncotarget
Published: May 16, 2018

COPD monocytes demonstrate impaired migratory ability.

COPD monocytes demonstrate impaired migratory ability.

Journal: Respiratory research
Published: November 21, 2016

Inhibitors of JAK-family kinases: an update on the patent literature 2013-2015, part 1.

Inhibitors of JAK-family kinases: an update on the patent literature 2013-2015, part 1.

Journal: Expert opinion on therapeutic patents
Published: October 25, 2016

Inhibitors of JAK-family kinases: an update on the patent literature 2013-2015, part 2.

Inhibitors of JAK-family kinases: an update on the patent literature 2013-2015, part 2.

Journal: Expert opinion on therapeutic patents
Published: October 25, 2016

Patient stratification and the unmet need in asthma.

Patient stratification and the unmet need in asthma.

Journal: Pharmacology & therapeutics
Published: January 11, 2016

Research in progress: Medical Research Council United Kingdom Refractory Asthma Stratification Programme (RASP-UK).

Research in progress: Medical Research Council United Kingdom Refractory Asthma Stratification Programme (RASP-UK).

Journal: Thorax
Published: May 28, 2015

OX40 blockade inhibits house dust mite driven allergic lung inflammation in mice and in vitro allergic responses in humans.

OX40 blockade inhibits house dust mite driven allergic lung inflammation in mice and in vitro allergic responses in humans.

Journal: European journal of immunology
Published: August 29, 2014
Showing 1-12 of 15

Last Updated: 09/26/2026